HHS To Spend $60M Developing Advanced Generic Drug Making Tech

By Gabrielle Wanneh / June 8, 2021 at 5:00 AM

The Biden administration is committing $60 million to develop technology that improves manufacturing of complex generic drugs, the White House announced Tuesday (June 8).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.